Cargando…

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease

Epidemiological data suggest a sexual dimorphism in Parkinson disease (PD), with women showing lower risk of developing PD. Vulnerability of the nigrostriatal pathway may be influenced by exposure to estrogenic stimulation throughout fertile life. To further address this issue, we analyzed the progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Siani, Francesca, Greco, Rosaria, Levandis, Giovanna, Ghezzi, Cristina, Daviddi, Francesca, Demartini, Chiara, Vegeto, Elisabetta, Fuzzati-Armentero, Marie-Thérèse, Blandini, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449471/
https://www.ncbi.nlm.nih.gov/pubmed/28620274
http://dx.doi.org/10.3389/fnins.2017.00306
_version_ 1783239785056305152
author Siani, Francesca
Greco, Rosaria
Levandis, Giovanna
Ghezzi, Cristina
Daviddi, Francesca
Demartini, Chiara
Vegeto, Elisabetta
Fuzzati-Armentero, Marie-Thérèse
Blandini, Fabio
author_facet Siani, Francesca
Greco, Rosaria
Levandis, Giovanna
Ghezzi, Cristina
Daviddi, Francesca
Demartini, Chiara
Vegeto, Elisabetta
Fuzzati-Armentero, Marie-Thérèse
Blandini, Fabio
author_sort Siani, Francesca
collection PubMed
description Epidemiological data suggest a sexual dimorphism in Parkinson disease (PD), with women showing lower risk of developing PD. Vulnerability of the nigrostriatal pathway may be influenced by exposure to estrogenic stimulation throughout fertile life. To further address this issue, we analyzed the progression of nigrostriatal damage, microglia and astrocyte activation and microglia polarization triggered by intrastriatal injection of dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) in male, female and ovariectomized (OVX) mice, as well as in OVX mice supplemented with 17βestradiol (OVX+E). Animals were sacrificed at different time points following 6-OHDA injection and brain sections containing striatum and substantia nigra pars compacta (SNc) underwent immunohistochemistry for tyrosine hydroxylase (TH) (dopaminergic marker), immunofluorescence for IBA1 and GFAP (markers of microglia and astrocyte activation, respectively) and triple immunoflorescent to identify polarization of microglia toward the cytotoxic M1 (DAPI/IBA1/TNFα) or cytoprotective M2 (DAPI/IBA1/CD206) phenotype. SNc damage induced by 6-OHDA was significantly higher in OVX mice, as compared to all other experimental groups, at 7 and 14 days after surgery. Astrocyte activation was higher in OVX mice with respect the other experimental groups, at all time points. Microglial activation in the SNc was detected at earlier time points in male, female and OVX+E, while in OVX mice was detected at all time-points. Microglia polarization toward the M2, but not the M1, phenotype was detected in female and OVX+E mice, while the M1 phenotype was observed only in male and OVX mice. Our results support the protective effects of estrogens against nigrostriatal degeneration, suggesting that such effects may be mediated by an interaction with microglia, which tend to polarize preferentially toward an M2, cytoprotective phenotype in the presence of intense estrogenic stimulation.
format Online
Article
Text
id pubmed-5449471
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54494712017-06-15 Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease Siani, Francesca Greco, Rosaria Levandis, Giovanna Ghezzi, Cristina Daviddi, Francesca Demartini, Chiara Vegeto, Elisabetta Fuzzati-Armentero, Marie-Thérèse Blandini, Fabio Front Neurosci Neuroscience Epidemiological data suggest a sexual dimorphism in Parkinson disease (PD), with women showing lower risk of developing PD. Vulnerability of the nigrostriatal pathway may be influenced by exposure to estrogenic stimulation throughout fertile life. To further address this issue, we analyzed the progression of nigrostriatal damage, microglia and astrocyte activation and microglia polarization triggered by intrastriatal injection of dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) in male, female and ovariectomized (OVX) mice, as well as in OVX mice supplemented with 17βestradiol (OVX+E). Animals were sacrificed at different time points following 6-OHDA injection and brain sections containing striatum and substantia nigra pars compacta (SNc) underwent immunohistochemistry for tyrosine hydroxylase (TH) (dopaminergic marker), immunofluorescence for IBA1 and GFAP (markers of microglia and astrocyte activation, respectively) and triple immunoflorescent to identify polarization of microglia toward the cytotoxic M1 (DAPI/IBA1/TNFα) or cytoprotective M2 (DAPI/IBA1/CD206) phenotype. SNc damage induced by 6-OHDA was significantly higher in OVX mice, as compared to all other experimental groups, at 7 and 14 days after surgery. Astrocyte activation was higher in OVX mice with respect the other experimental groups, at all time points. Microglial activation in the SNc was detected at earlier time points in male, female and OVX+E, while in OVX mice was detected at all time-points. Microglia polarization toward the M2, but not the M1, phenotype was detected in female and OVX+E mice, while the M1 phenotype was observed only in male and OVX mice. Our results support the protective effects of estrogens against nigrostriatal degeneration, suggesting that such effects may be mediated by an interaction with microglia, which tend to polarize preferentially toward an M2, cytoprotective phenotype in the presence of intense estrogenic stimulation. Frontiers Media S.A. 2017-05-31 /pmc/articles/PMC5449471/ /pubmed/28620274 http://dx.doi.org/10.3389/fnins.2017.00306 Text en Copyright © 2017 Siani, Greco, Levandis, Ghezzi, Daviddi, Demartini, Vegeto, Fuzzati-Armentero and Blandini. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Siani, Francesca
Greco, Rosaria
Levandis, Giovanna
Ghezzi, Cristina
Daviddi, Francesca
Demartini, Chiara
Vegeto, Elisabetta
Fuzzati-Armentero, Marie-Thérèse
Blandini, Fabio
Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
title Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
title_full Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
title_fullStr Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
title_full_unstemmed Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
title_short Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
title_sort influence of estrogen modulation on glia activation in a murine model of parkinson's disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449471/
https://www.ncbi.nlm.nih.gov/pubmed/28620274
http://dx.doi.org/10.3389/fnins.2017.00306
work_keys_str_mv AT sianifrancesca influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT grecorosaria influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT levandisgiovanna influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT ghezzicristina influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT daviddifrancesca influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT demartinichiara influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT vegetoelisabetta influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT fuzzatiarmenteromarietherese influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease
AT blandinifabio influenceofestrogenmodulationongliaactivationinamurinemodelofparkinsonsdisease